
Developer and Manufacturer of Health-related Electronic Products and Smart Hardware
Intelligent Rehabilitation Equipment R&D and Manufacturer

In Vitro Diagnostic Reagent Manufacturer
Comprehensive Solution Provider for Clinical Diagnosis and Treatment


Capacity Expansion and Investment
BD: Planned Investment3500 Million USD to expand the capacity of pre-filled flush syringes at the Columbus, Nebraska plant in the United States.Newly added approximately50 One position, with key supportPosiFlush Pre-filled syringe production line is expected to produce hundreds of millions of additional units annually to meet the needs of the U.S. healthcare system. This investment is part of its five-year plan for the U.S.25 Part of the hundred million US dollar production capacity enhancement plan, with investments related to this product exceeding8000 Million USD.
B. Braun (Beilang): Costing5 Billion dollars to complete the Irvine Park (29 Acres) Modernization and Upgrade of Intravenous Fluids and Bags Production Line`, Belonging to`2019 Launched in10 USD billion reinvestment plan across the entire company; new factory in Daytona Beach, Florida, has opened, doubling intravenous infusion production capacity. New additions after Hurricane Helen.200 Employees, increase output20%, and there are still100 Multiple job vacancies. In addition, the Irvine plant90% The above-mentioned power is supplied by fuel cells, with the goal of...2030 Annual carbon emissions halved.
Andon Health: Establishes Two New Wholly-Owned Electronic Technology Companies in Tianjin (Tianjin Jiushun, Jiuai Electronics),The registered capital is 50 10,000 yuan.
Sunnyou Medical: Newly Established Wholly-Owned Subsidiary Tianjin Jiechuang Rui Intelligent Technology Co., Ltd.,Business scope includes AI industry applications, intelligent robot R&D and sales, etc.
Sunflower Pharmaceutical: Investment 1000 Established a wholly-owned subsidiary, Kuihua Health Technology, with an investment of 10,000 yuan.(Andon Health)Co., Ltd.,Business scope covers medical device operation, food production, etc., expanding the broader health industry chain.
Investment, Financing and Mergers & Acquisitions
Tellgen: Plans to 3.28 Step-by-Step Acquisition of Kanglu Bio for Hundreds of Millions82% Shares, expanding the precision oncology diagnostics business.
Anhui Kemi Machinery Technology Co.,LTD.: Completes Tens of Millions of Yuan B Round of financing (led by Chuangjing Capital)), the funds will be used for high-end synthesis equipment, small and medium-scale trial and industrialization synthesis reaction equipment, continuous flow technology iteration, and global business expansion.
Liaoning Health Commission Color Doppler Ultrasound Centralized Procurement:Total Budget 1.34 100 million yuan, procurement87 Set of desktop color Doppler ultrasound systems (Requirements5 Year warranty), Mindray ultrasound wins bid40 Set (2384.8 RMB 10,000), Neusoft Medical Systems Co.,Ltd. wins the bid47 Set (5115 (Ten Thousand Yuan).
Shanxi Health Commission's Centralized Procurement of Radiological Equipment: Total Budget 9010 Ten Thousand Yuan, Procurement69 SetDR And24 SetC C-arm (requirement for2025 Year1 Month1 New machines produced in the future will have full factory warranty.5 Year, including the protection and decoration of the radiology room, divided5 Section ). Among them, Wandong Medical won the bid61 SetDR(2911.5 RMB 10,000), Neusoft Medical Systems Co.,Ltd. wins the bid24 SetC C-arm (797.2 (Ten Thousand Yuan),8 SetDR The bid was rejected due to an insufficient number of bidding suppliers.
Product Approval and Launch
Maiview Medical: World's First Nanosecond Pulsed Field Ablation (ns-PFA) SystemNxPFA™ObtainNMPA Approval.
Fujifilm: Launches New Generation Portable Digital X RayFDR Go iQ,Features slim and lightweight design, intelligent charging,3D Characteristics such as positioning guidance, suitable for emergency and intensive care scenarios.
Personnel Changes
RxSight: AppointmentRaymond W. Cohen For Board Members`, whose previous name was`Axonics Co-founder andCEO, led the acquisition of the company by Boston Scientific and participated in multiple medical technology company transactions.
United States FDA: AppointmentSean Keveney For the New Chief Legal Counsel, responsible for overseeing all legal affairs, previously served as the Acting General Counsel of the U.S. Department of Health and Human Services.
Enterprise Market Value and Strategy
Tellgen: Market Value Breaks for the First Time 200 100 million yuan,Stock price hits a record high (YTD increase250.1%); but2024 Revenue and net profit decline year on year. The main business is in vitro diagnostic reagents, and the company is advancing.“Diagnosis+ Innovative Drug” Strategy, Layout in Antibody Drugs and Nucleic Acid Drugs Fields.
Want to stay on top of the latest news and in-depth insights from the medical device industry? Add the official customer service WeChat account of "Medical Device Innovation Network" to join an exclusive reader group. In this group, you can get real-time updates on industry trends, communicate with peers, and share your questions, insights, and expectations, allowing your thoughts to resonate and spark discussions within the community.



Previous Recommendations
Medical Device Companies Race for IPO: Who Will Follow in the Footsteps of Bixin Life?
